Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.

Miller JM, Everett BA, Oquendo MA, Ogden RT, Mann JJ, Parsey RV.

Synapse. 2016 Jan;70(1):24-32. doi: 10.1002/syn.21868. Epub 2015 Oct 19.

2.

Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.

Yeh YW, Ho PS, Chen CY, Kuo SC, Liang CS, Ma KH, Shiue CY, Huang WS, Cheng CY, Wang TY, Lu RB, Huang SY.

Int J Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu065. doi: 10.1093/ijnp/pyu065.

3.

Meta-analysis of molecular imaging of serotonin transporters in major depression.

Gryglewski G, Lanzenberger R, Kranz GS, Cumming P.

J Cereb Blood Flow Metab. 2014 Jul;34(7):1096-103. doi: 10.1038/jcbfm.2014.82. Epub 2014 May 7.

4.

Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.

Watkins CC, Sawa A, Pomper MG.

Transl Psychiatry. 2014 Jan 21;4:e350. doi: 10.1038/tp.2013.119. Review.

5.

Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123) I]-ADAM SPECT.

Amsterdam JD, Newberg AB, Newman CF, Shults J, Wintering N, Soeller I.

J Neuroimaging. 2013 Oct;23(4):469-76. doi: 10.1111/jon.12035. Epub 2013 Jun 10.

6.

Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.

Miller JM, Hesselgrave N, Ogden RT, Sullivan GM, Oquendo MA, Mann JJ, Parsey RV.

Biol Psychiatry. 2013 Aug 15;74(4):287-95. doi: 10.1016/j.biopsych.2013.01.024. Epub 2013 Mar 1.

7.

Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins.

Sugawara H, Iwamoto K, Bundo M, Ueda J, Miyauchi T, Komori A, Kazuno A, Adati N, Kusumi I, Okazaki Y, Ishigooka J, Kojima T, Kato T.

Transl Psychiatry. 2011 Jul 26;1:e24. doi: 10.1038/tp.2011.26.

8.

Low brain serotonin transporter binding in major depressive disorder.

Newberg AB, Amsterdam JD, Wintering N, Shults J.

Psychiatry Res. 2012 May 31;202(2):161-7. doi: 10.1016/j.pscychresns.2011.12.015. Epub 2012 Jun 12.

9.

A non-synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: results of a genome-wide association study.

Liu X, Cannon DM, Akula N, Moya PR, Knudsen GM, Arentzen TE, Steele J, Laje G, Drevets WC, McMahon FJ.

Mol Psychiatry. 2011 Jun;16(6):584-5. doi: 10.1038/mp.2011.1. Epub 2011 Feb 22. No abstract available.

10.

Adverse early life experience and social stress during adulthood interact to increase serotonin transporter mRNA expression.

Gardner KL, Hale MW, Lightman SL, Plotsky PM, Lowry CA.

Brain Res. 2009 Dec 11;1305:47-63. doi: 10.1016/j.brainres.2009.09.065. Epub 2009 Sep 23.

11.

Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

Rajkumar R, Mahesh R.

Curr Neuropharmacol. 2008 Sep;6(3):215-34. doi: 10.2174/157015908785777256.

12.

Imaging phenotypes of major depressive disorder: genetic correlates.

Savitz JB, Drevets WC.

Neuroscience. 2009 Nov 24;164(1):300-30. doi: 10.1016/j.neuroscience.2009.03.082. Epub 2009 Apr 7. Review.

13.

Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder.

Miller JM, Kinnally EL, Ogden RT, Oquendo MA, Mann JJ, Parsey RV.

Synapse. 2009 Jul;63(7):565-73. doi: 10.1002/syn.20637.

14.

Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.

Miller JM, Oquendo MA, Ogden RT, Mann JJ, Parsey RV.

J Psychiatr Res. 2008 Oct;42(14):1137-44. doi: 10.1016/j.jpsychires.2008.01.012. Epub 2008 Mar 10.

15.
16.

Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography.

Oquendo MA, Hastings RS, Huang YY, Simpson N, Ogden RT, Hu XZ, Goldman D, Arango V, Van Heertum RL, Mann JJ, Parsey RV.

Arch Gen Psychiatry. 2007 Feb;64(2):201-8.

17.

Elevated midbrain serotonin transporter availability in mixed mania: a case report.

Tolmunen T, Joensuu M, Saarinen PI, Mussalo H, Ahola P, Vanninen R, Kuikka J, Tiihonen J, Lehtonen J.

BMC Psychiatry. 2004 Sep 13;4:27.

18.

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.

Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS.

Neuropsychopharmacology. 2004 Aug;29(8):1426-31.

Supplemental Content

Support Center